dr megan carter glp 1 NEW SERIES with @drcristie where she talks about a hot topic right now: Medications✨, GLP 1s are great tools, but they don’t reach their full potential on their own magnetptecon #nursing #nursingexcellence | Dr.

Weight regain was the primary outcome and was modelled using nonlinear regression

With ultra-fine needles, these syringes ensure less pain and anxiety during daily diabetes treatment, while the sterile, disposable design prevents cross-contamination and infection

Available in low-sugar and sugar-free options

Kalah will join fellow panelists Wade Ackerman, Sean Griffin and Scott Brunner, CAE for the session, Taking Shape: The Legislative and Regulatory Landscape for GLP-1s. Together, the panel will explore: Pending legislation impacting GLP-1 marketing, manufacturing, compounding, and access FDA enforcement activity and evolving regulatory posture Drug pricing and Medicare negotiation implications State AG activity and broader policy pressures influencing regulators How companies can prepare for pending and potential legislation before it takes effect If youll be attending the summit, be sure to add this discussion to your agenda

Learn the latest 2026 recommendations for perioperative diabetes management, including GLP-1 receptor agonists, SGLT2 inhibitors, metformin, anesthesia risks, aspiration concerns, and surgical care guidelines for patients with diabetes.